COMMUNIQUÉS West-GlobeNewswire

Direct Meds Updates DirectMax Clinical Review and Licensed-Pharmacy Fulfillment Details (2026)
18/08/2026
Direct Meds has broadened the patient-facing information available for DirectMax, covering its online clinical-review process, the compounded status of the medication, its licensed-pharmacy fulfillment model, recurring- [...]
FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
18/08/2026
Discussion Paper Supports FDA’s Innovation and Global Leadership Strategic Pillar; Public Docket Opens on Regulations.gov Silver Spring, Md., Aug. 18, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today [...]
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
18/08/2026
Acquisition expands Cellution Biologics’ human tissue-based portfolio and marks its entry into the U.S. reconstructive surgery market ROSWELL, Ga., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc. (“Cellution [...]
Peak Physio Launches Subscription Education Platform Arcane Physio for International Clinician Market
18/08/2026
Physiotherapist Laith Cunneen on Channel 7’s Sunrise. Supplied by Arcane Physio Peak Physio has opened Arcane Physio, a clinical education and reference platform, to external subscribers, targeting physiotherapists [...]
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC
18/08/2026
SAN DIEGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative [...]
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
18/08/2026
Asimov will use its CHO Edge System to develop a high-titer cell line for Kaigene’s novel multispecific antibody that selectively degrades pathogenic antibodies. BOSTON, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Asimov, the [...]
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
18/08/2026
As a global medical cannabis leader, Tilray Medical supports continued policy development that strengthens physician confidence, protects patient access and provides a clear, sustainable framework for medical cannabis [...]
ABBYY’s New Executive Appointments Illustrate Focus on Hybrid AI to Drive Enterprise Intelligence
18/08/2026
Robert Hucik promoted to Chief Technology Officer and Joe Rayfield hired as SVP of Sales for the Americas and EMEA AUSTIN, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ABBYY today announced it promoted Robert Hucik to Chief [...]
Immatics Announces Second Quarter 2026 Financial Results and Business Update
18/08/2026
Enrollment in the SUPRAME Phase 3 trial of anzu-cel (anzutresgene autoleucel, IMA203) remains on track to complete the required randomizations by year-end to support final analysis for the primary PFS endpoint; [...]
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
18/08/2026
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company [...]
General Oncology Nominated for the 2026 Prix Galien USA Best Startup Award
18/08/2026
Recognition follows preliminary Phase 1 results presented at ESMO Congress 2025 for GO-4 in BRCA/PALB2-mutated stage IV pancreatic ductal adenocarcinoma, where two patients remain progression-free at 48 and 23 months [...]
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
18/08/2026
Former Intra-Cellular Therapies, Inc. (“Intra-Cellular”) executives bring complementary experience in organizational scale-up, central nervous system (“CNS”) drug development, regulatory approvals and commercialization [...]
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
18/08/2026
Total revenue of $46.5 million, up ~288% YoY (~3.9x); within the Company’s guidance of $46-48 million IM8 revenue of $45.0 million, up ~359% YoY (~4.6x); within the Company’s guidance of $44-46 million, marking the [...]
BrewDog Unwraps Its 2026 Advent Calendar
18/08/2026
New brews, bold flavours and one unmissable 24-day countdown to Christmas ELLON, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Scottish craft brewer BrewDog , by Tilray Brands, Inc. , today unveiled its 2026 Advent [...]
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
18/08/2026
Primary endpoint achieved, demonstrating a 70% economic advantage over allograft based on product cost per percent total body surface area treated (p<0.001) 96% reduction in preparation time and comparable clinical [...]
PROMIXX Pursuit Insulated Shaker Bottle Keeps Protein Shakes Ice Cold for 12+ Hours, Outlasting Standard Gym Bottles
18/08/2026
Dual wall vacuum insulated design is built for full gym sessions, commutes and all day use, without the drink going warm CARDIFF, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- As gym sessions run longer through the [...]
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
18/08/2026
Dr. Camisasca joins Entera with 30 years of global pharmaceutical research and clinical development experience including roles at Sumitomo Pharma, Takeda, and Novartis Appointment further strengthens Entera’s clinical [...]
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
18/08/2026
BRANFORD, Conn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule [...]
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
18/08/2026
Deal valued at $11 million in cash, with $8 million at closing and up to $3 million in additional milestone payments over the next 18 months Divestiture further concentrates Elutia’s attention and resources on the [...]

Pages